INTRODUCTION
The gaseous messenger nitric oxide (NO) plays numerous roles during all stages of life, and evidence of its importance in development of the nervous system continues to grow. Studies in insects indicate that NO is an important intercellular signal in neural development, playing a role at developing neuromuscular junctions in the locust (Truman et al., 1996; Ball and Truman, 1998) , in the visual system of Drosophila melanogaster (Gibbs and Truman, 1998) , and in the antennal (olfactory) system of Manduca sexta (Schachtner et al., 1999a,b) , where an NO-stimulated rise in cGMP may be important in synapse formation. In developing vertebrate olfactory systems, NO appears to synchronize differentiation of precursors of olfactory receptor cells (ORCs) and to modulate stabilization of synapses made by ORC axon terminals (Roskams et al., 1994; Arnhold et al., 1997) .
Using the moth M. sexta as a model system, we are further investigating the role of NO in the development of the adult's olfactory system. In previous papers, we have described the cloning and characterization of the gene for M. sexta NO synthase (MsNOS; Nighorn et al., 1998) and its expression in the developing adult olfactory system (Gibson and Nighorn, 2000) . An important question raised by those studies was whether NO produced by ORC axons acts as an intercellular signal mediating some of the effects of ORC axons on development of their targets. During metamorphic development in M. sexta, ORC axons play a crucial role in establishing the glomerular architecture of the adult antennal (olfactory) lobes in the brain. Upon arrival in the lobes, the axons arborize in neuropil structures that are often spheroidal and are called protoglomeruli. The three-dimensional structure initially established by the ORC terminal branches is ephemeral; glial cells must migrate to define the borders of the developing glomeruli or these subdivisions will disappear Baumann et al., 1996) . If ORC axons are prevented from reaching the lobes, glial cells fail to migrate, and the neurons of the antennal lobe fail to adopt the glomerular arborizations characteristic of vertebrate and many invertebrate primary olfactory neuropils (Hildebrand et al., 1979; Oland and Tolbert, 1987; Tolbert and Sirianni, 1990) . The mechanisms by which the ORC axons define the glomeruli and by which the glia stabilize them remain largely unknown .
Because MsNOS is expressed by ORC axons throughout metamorphosis (Nighorn et al., 1998; Gibson and Nighorn, 2000) , NO is a candidate molecule by which these ingrowing axons could signal to glial cells and/or neurons in the antennal lobe. We have addressed the dual questions of whether NO is generated by MsNOS during development of the antennal system and, if so, what role it plays. We have used the NOS inhibitor L-NAME and the NO scavenger carboxy-PTIO (CPTIO) to block NO signaling during the early stages of axon ingrowth when the protoglomerular template is formed and construction of glomeruli begins. Our results suggest that NO is indeed produced beginning very early in development and that it plays an important role in establishing antennal-lobe architecture. To determine how NO effects are mediated, we have investigated the possible involvement of several biochemical pathways. The results of perturbation experiments indicate that ADPribosylation, but not activation of soluble guanylyl cyclase (sGC), is involved. Some of these results have been reported previously in abstract form (Gibson et al., 1999) .
MATERIALS AND METHODS

Animals
Male M. sexta (Lepidoptera: Sphingidae) were reared from eggs on an artificial diet in a laboratory colony as previously described . Rearing conditions were 26°C, 50 -60% relative humidity, and a long-day photoperiod (17 h light, 7 h dark). Metamorphic development, when the adult antennal system develops, can be divided into 18 stages, each lasting 1-4 days, which span the time from pupation to eclosion. Animals were staged according to features, such as eye pigmentation and leg development, visible through the cuticle under fiber-optic illumination as described by Tolbert et al. (1983) and Oland and Tolbert (1987) . Staging of experimentally treated animals was complicated by a tendency toward desynchronization of these markers; in such cases, the most advanced of the markers was used to estimate developmental stage. In general, this did not cause a problem with interpretation of results as the effects were robust and consistent, regardless of the apparent stage at which the experiment was terminated.
Drug Treatment
L-NAME and D-NAME treatment. Animals were treated with L-NAME or D-NAME by using one of two methods: METHOD 1. Animals at stage mid 2 to early 3 of metamorphosis were anaesthetized in CO 2 for 20 min, and then injected with 30 l 1.33 M N -nitro-L-arginine methyl ester (L-NAME; Sigma #N5751) or N -nitro-D-arginine methyl ester (D-NAME; Sigma #N4770) dissolved in phosphate-buffered saline, pH 7.4 (PBS). Injections, using a microliter syringe and 27-gauge needle inserted from the side into the head anterior to the brain, were given at approximately 08:00 and 17:00 on three consecutive days. The injection sites were sealed with melted dental wax. Because individual M. sexta contain approximately 2 ml of hemolymph at these early stages (extrapolated from data from Morton and Truman, 1985) , each injection should have given an initial circulating concentration of approximately 20 mM. Using this method, 36 animals were treated with L-NAME, and 11 animals were treated with D-NAME. METHOD 2. Animals at stages mid 2 to early 3 were anaesthetized with CO 2 as above. Polyethylene tubing (Clay Adams, Parsippany, NJ; #7410) was inserted into the midthorax at 45°from the dorsal midline or through the head cuticle at the point where the proboscis joins it, and waxed into place. Next, 30 l of a 1.33 M solution of L-NAME in PBS was injected immediately; an additional 150 l of solution was then infused over a period of 72 h by using a syringe pump (Sage Instruments, model 355). Three animals were treated using this method.
In all cases, treated animals were returned to the insect-rearing facility to continue development to the desired stage. L-NAMEtreated animals often did not progress beyond about stage 12 of metamorphic adult development, although some did proceed through eclosion to adulthood. Assuming a hemolymph volume of 2 ml, the 180 -200 l of drug-plus-vehicle used in most experiments presumably increased the volume by approximately 10% over the 72-h injection/infusion period in this closed system. Control injections of vehicle (PBS) alone produced no obvious effects.
Carboxy-PTIO treatment. 2-(4-Carboxyphenyl)-4,4,5,5-tetramethylimidazoline-3-oxide-1-oxyl (CPTIO, Dojindo #C348-12, Kumamoto, Japan), dissolved in PBS to give 200 l of a 250 mM solution, was injected as described in "Method 2" above, using a 30-l bolus and a 72-h period for injecting the remaining 170 l. Circulating concentrations are estimated to have started at 3.75 mM, rising to 25 mM. Animals were dissected at developmental stages 5-8. Nine animals were treated by using this method.
Novobiocin treatment. A single dose of Novobiocin (Sigma #N1628; 20 l of a 100 mM aqueous solution) was injected directly through the head cuticle into the vicinity of the left optic lobe of midstage-2 or early stage-3 animals. The injection site was sealed with wax and the animals returned to the rearing facility to develop. Some Novobiocin-treated animals were permitted to progress through metamorphosis; these animals all emerged as adults, although many exhibited impaired motor function and required help to escape from the pupal cuticle. Forty-nine animals were treated by using this method.
ODQ treatment. 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ, Calbiochem #495320) was dissolved in 100% DMSO to make a 100-mM stock solution. This stock was diluted 100-fold in PBS to 1 mM in 1% DMSO and infused (with or without a 30-l bolus) over 48 h at total volumes of 50, 100, and 250 l, to give approximate hemolymph concentrations of 25, 50, and 125 M. Ten animals were treated by using this method, one each at 50 and 100 l, and eight at 250 l (7 with a bolus). Experiments in which 180 l of 100% DMSO was infused over 48 h produced no observable effects on development of the antennal lobe.
Immunocytochemistry
In all cases, 4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4, was used as the fixative. Unless otherwise noted, all immuno-cytochemical and labeling steps were done on a shaker at room temperature. Secondary antibody controls in which no primary antibody was used gave no discernable image at the confocal microscope settings used for the experimental images.
NOS immunocytochemistry. Animals were anaesthetized on ice. Antennae were fixed in situ for 20 min, removed and cut into 10-segment lengths, then fixed overnight at 4°C. Antennae were washed in PBS, embedded in 5% agarose (Sigma, #A-0169), and cross-sectioned with a vibrating microtome (Vibratome, Technical Products International, St. Louis, MO) at 150 m. Sections were processed as described in Gibson and Nighorn (2000) by using a universal NOS antibody (uNOS; Oncogene Research Products #PC201, Cambridge, MA) and secondary antibodies conjugated to Alexa 546 or 488 dye (Molecular Probes, Eugene, OR).
Serotonin immunocytochemistry. Brains were dissected under insect saline (150 mM NaCl, 4 mM KCl, 6 mM CaCl 2 , 10 mM Hepes, 5 mM glucose, pH 7.0, adjusted to 360 mOsm with mannitol), and then fixed, embedded, and sectioned at 50 -150 m as above. Sections were incubated in PBS with 0.5% Triton X-100 and 0.1% sodium azide (PBSAT) with 5% normal goat serum with or without 5% normal donkey serum for 1-2 h, washed two times in PBST, and then incubated overnight in rabbit anti-serotonin (5-HT, 1:4000, Incstar, now DiaSorin, Stillwater, MN) in PBSAT with 5% normal goat serum. Sections were washed five times in PBST, incubated for 1 h in PBSAT with 5% normal goat serum, and then incubated overnight in Cy5-conjugated goat anti-rabbit antibody (1:250; Jackson ImmunoResearch, West Grove, PA) in PBSAT with 5% normal goat serum. Sections were washed five times in PBST and two times in PBS, then mounted as described below. Sections blocked with a combination of goat and donkey serum displayed far less nonspecific speckled staining than those blocked with goat serum alone.
SNP and IBMX pretreatment for cGMP immunocytochemistry. Prior to cGMP immunocytochemistry, brains were dissected as above, then incubated for 60 min in insect saline at room temperature, incubated for 20 min in insect saline containing 1 mM sodium nitroprusside (SNP, Sigma #S0501, an NO donor to stimulate soluble guanylyl cyclase) plus 10 mM 3-isobutyl-1-methylxanthine (IBMX, Calbiochem #410957, a phosphodiesterase inhibitor), and then rinsed and fixed. cGMP immunocytochemistry. Brains treated with SNP and IBMX were fixed, washed, embedded, and Vibratome-sectioned at 200 m. Sections were incubated in PBSAT with 2% normal donkey serum for 1 h. Sheep polyclonal anti-cGMP antiserum (1:10,000, H. Steinbusch, The Netherlands) was added and the sections incubated overnight. Sections were then washed, blocked as above, and incubated for 1 h with Cy5-conjugated donkey anti-sheep antibody (1:250, Jackson Laboratories). Sections were washed five times in PBST and two times in PBS, then mounted as described below.
cGMP-5-HT double-label immunocytochemistry. Brains were processed as for cGMP immunocytochemistry, using normal donkey serum in the antibody steps. Sections were then washed four times in PBST, blocked for 1 h in PBST with 2% normal goat serum, and incubated overnight in rabbit anti-5-HT (1:4000 in PBST with 2% normal goat serum). Sections were washed five times in PBST, blocked for 1 h in PBST with 2% normal goat serum, then incubated for 1 h in goat anti-rabbit antibody conjugated to Alexa 488 (1:250, Molecular Probes). Sections were washed five times in PBST and two times in PBS, then mounted as described below.
Labeling of Glia
Labeling of nuclei. To label nuclei, including those of glial cells, sections were first treated with 100 g/ml RNase A (Sigma #R5503) in PBS for 15 min to reduce RNA staining in glial processes, then washed, incubated in 25 g/ml propidium iodide (Molecular Probes, Eugene, OR; #P-1304) in PBS for 15 min, and washed again.
Labeling of processes. Lycopersicon esculentum lectin (LEL) was used to label glial processes. Sections were incubated in LEL-FITC (1:100 in PBS; Vector Laboratories, Burlingame, CA, # FL-1171) for 1-2 h, then washed three times in PBS. Lectin staining necessarily preceded immunocytochemistry, as exposure to Triton X-100 reduced specific lectin labeling while increasing background labeling. Treatment with Triton after lectin labeling had no observable effect on labeling intensity.
Labeling of Axons of Olfactory Receptor Cells
Ingrowth and arborization of ORC axons were studied by masslabeling of the axons with the lipophilic dyes 3,3Ј-dioctadecyloxacarbocyanine perchlorate (DiO; Molecular Probes #D-275) or 1,1Ј-dioctadecyl-3,3,3Ј,3Ј-tetramethylindodicarbocyanine, 4-chlorobenzene-sulfonate salt (DiD; Molecular Probes #D-7757), as described by Rö ssler et al. (1998) . Brains were fixed overnight at 4°C in standard fixative plus 0.15% glutaraldehyde. Small crystals of the dyes were inserted into the antennal nerves by using a fine insect pin. The brains were then returned to the fixative solution and stored at room temperature for 7 days to allow the dyes to diffuse along the axons. The brains were then washed, sectioned, and labeled with propidium iodide (and, for DiD, with LEL-FITC) as described above.
Confocal Microscopy
Sections were mounted in PBS ϩ 80% glycerol and viewed on a Nikon PCM 2000 laser scanning confocal microscope by using Simple PCI software (Compix Inc., Cranberry Township, PA). Serial optical sections were imaged at 1-to 5-m intervals through the depth of the Vibratome sections and saved as three-dimensional stacks.
Image processing. Confocal image stacks were projected and merged in false color by using Confocal Assistant (copyrighted by Todd Brelje, distributed by Bio-Rad, Richmond, CA), and then imported into Corel Photopaint, where image hue, intensity, and contrast were adjusted for maximum clarity. The images were then combined into figures in Corel Draw, where annotations were added.
RESULTS
Involvement of NO in Development of the Antennal System
To address whether NO plays a role in development of the antennal system in M. sexta, we sought to block NO signaling during metamorphic development. Two compounds, affecting different aspects of the NO signaling pathway, were used: L-NAME competes with arginine for binding in the NOS active site, thereby blocking conversion of arginine to NO and citrulline (Rees et al., 1990) , and CPTIO scavenges NO molecules once they are produced, converting them to NO 2 Ϫ and NO 3 Ϫ (Akaike et al., 1993) . ORC axons reach the developing antennal lobe beginning at late stage 3 and form protoglomeruli during stage 5. The neuropil-associated glia, which form a shell several cells thick around the neuropil prior to axon ingrowth, then extend processes and migrate to nearly surround the protoglomeruli (Oland and Tolbert, 1987) . Because MsNOS is present in ingrowing ORC axons by stage 3 (unpublished observation), NO-related events initiated by the axons might begin as early as stage 3. Therefore, treatments to block NO signaling were begun during late stage 2. Earlier injections usually arrested development for as long as 2-4 weeks, possibly owing to an effect of L-NAME on the Ia1 neurosecretory cells (Homberg et al., 1991) , which we found to be strongly NOS-immunoreactive (not shown). Later injections had no apparent effect on normal phenotype.
The brains of L-NAME-and CPTIO-treated animals displayed several characteristic gross abnormalities. Regardless of the method used, brains of treated animals typically displayed smaller than normal antennal lobes and antennal nerves, and a larger than normal esophageal foramen (a representation of these differences is diagramed in Fig. 1 ). Antennal lobes of treated animals generally were located more ventrolaterally, indicating that the lobes had not migrated dorsally relative to other brain structures as they do during normal development.
Experiments involving two injections of L-NAME per day for 3 days (Method 1) perturbed antennal-lobe morphology to varying degrees (Figs. 2B, 2D , and 2G). The most prominent feature of the experimental lobes was the partial or complete absence of the regular periglomerular arrangement of the neuropil-associated glial cells (Fig. 2D) , even when axons made normal-appearing protoglomeruli in the same preparation (Fig. 2B) . In control animals injected with vehicle or with vehicle plus D-NAME, the inactive enantiomer, glial cells migrated to surround glomeruli in the normal fashion (shown for D-NAME, Fig. 2E ). In many L-NAME-treated animals, the pattern of distribution of glial cells did not reflect the distribution of axonal protoglomeruli (Figs. 2B and 2D ). In others, some glial cells migrated to surround protoglomeruli (not shown), but the dendrites of the serotonin-immunoreactive (5-HT ϩ ) neuron, a useful reporter for the development of antennal-lobe interneurons (Kent, 1987; Oland et al., 1995) , branched abnormally throughout the entire glomerulus (Fig. 2G) , whereas dendritic branches in untreated or control animals were restricted to the basal half of the glomerulus, with a few relatively straight branches extending into the outer half of the glomerulus (Figs. 2F and 2H; see also Sun et al., 1993) .
To minimize possible production of NO during troughs in L-NAME levels in animals receiving discrete injections (Mü ller and Hildebrandt, 1995) , and also to minimize possible consequences of repeatedly subjecting animals to anaesthesia prior to injections, we delivered L-NAME continuously (Method 2) in three animals. The protocol consisted of a single 30-l bolus injection at late stage 2, immediately followed by a slow, syringe-pump infusion. The resulting antennal lobes were smaller than normal. Glial cells had accumulated abnormally around the perimeter of the neuropil (Fig. 3A) , and the dendrites of the 5-HT ϩ neuron branched in a diffuse, nonglomerular pattern (Fig.  3B) .
CPTIO, delivered by Method 2, gave results similar to those obtained with L-NAME. Neuropil-associated glial cells formed a rim around the neuropil (Fig. 3C) , and dendrites of the 5-HT ϩ neuron branched in a diffuse, nonglomerular pattern (Fig. 3D ). L-NAME-and CPTIO-treated animals which were allowed to develop to later stages (12-14, by which time the glomeruli normally have achieved their adult conformation) exhibited the same basic arrangement (not shown).
The disposition of the glial cells and the branching pattern of the 5-HT ϩ neuron in the L-NAME-and CPTIOtreated animals (Fig. 3) were similar to the cellular patterns seen in deafferented animals (Hildebrand et al., 1979; Oland and Tolbert, 1987; Tolbert and Sirianni, 1990; Oland et al., 1995) . Nevertheless, in all cases, a substantial antennal nerve, ranging from half the diameter of the normal nerve to normal thickness, was present. Because lack of glial migration could also be due to failure of ORC axons to form protoglomerular templates, we tested for the transient formation of protoglomeruli. When antennal nerves in treated animals dissected at stage early 5-7 were labeled with DiD, axons were seen to have made glomerulus-like structures (Fig. 4) . In one animal treated with CPTIO (Fig.  4A) , the antennal lobes exhibited thick bundles of ORC axons projecting to a few abnormally shaped protoglomerulus-like structures, while many axon terminals stalled in the region of the male-specific macroglomerular FIG. 1. Schematic representation of average appearance of the brains of untreated (A) and L-NAME-or CPTIO-treated (B) animals. In the latter, the antennal nerves were up to 50% smaller in diameter, and the antennal lobes (ALs) were generally smaller as well. The more ventrolateral location of the lobes in (B) is reminiscent of their location early in metamorphosis in normal animals. The esophageal foramen was also larger in the treated animals.
complex (MGC). In the majority of cases (11 of 13 treated animals), however, ORC axons formed protoglomeruli (Figs. 4B and 4C) . Thus, at least some of the axonal template for glomerulus development was in place, but glia did not migrate properly around the forming structures. The degree of glial migration seen at stages 5-7 was variable (Figs. 4D, 4E, and 4F); it was most pronounced in the region of the MGC and often absent at the ventromedial pole of the lobes.
One class of antennal-lobe glial cells responded normally to the presence of antennal axons. The glial cells that come to populate the axonal "sorting zone" migrated outward, into the base of the antennal nerve (Figs. 3A, 3C, 4D, 4E , and 4F), as they do in untreated animals .
These results suggest that NO, released by the ingrowing ORC axons, stimulates neuropil-associated glial cells to migrate to surround the protoglomeruli. Because MsNOS is present along the entire length of ORC axons (Gibson and Nighorn, 2000) , we asked whether it played an important role at other points in the olfactory pathway as well. Rö ssler et al. (1999) have shown that glial cells migrate from the olfactory epithelium in the antenna along nerve rootlets composed of ORC axons and then along the antennal nerve branches formed by the coalescence of rootlets. At stage 3, the glia are found only in the rootlets; by stage 5, many have migrated into the nerve branches (Fig. 5A) . In cross-sections of normal antennae at stage 5, olfactory receptor axons traveling near the surface of the antennal nerves are MsNOS-positive, while axons forming the nerve cores are NOS-negative (Fig. 5B , and Gibson and Nighorn, 2000) . Glial cells are seen in the nerve branch, but only on the 1, B, D) , and a D-NAME-treated (Method 1, E) animal. Animals were dissected at apparent stages 7 (untreated, L-NAME) and 8 (D-NAME). Protoglomeruli (arrows) were seen to have formed in the L-NAME-treated animal (B), but glial migration was absent (D, lower left) or disorganized (D, middle of figure). Glial migration was normal in the untreated (C) and D-NAME-treated (E) animals. Images are projections of optical sections spaced at 4 m and represent a total thickness of 16 m. Scale bar, 100 m. (F-H) Anti-5-HT labeling of dendrites of the 5-HT ϩ neuron in untreated (F), L-NAME-treated (Method 1, G) and D-NAME-treated (Method 1, H) animals at approximate stage 12. The arborization in untreated and D-NAME-treated animals is confined to the inner halves of the glomeruli with a few tufts extending into the outer halves (F, H), while in the L-NAME-treated animal the arborization extends throughout the glomeruli. Images are projections of optical sections spaced at 3 m corresponding to a total thickness of 6 (F), 21 (G), and 20 m (H). Scale bar, 50 m.
surface and in the area where rootlets have joined the branch. Glial distribution correlates well with areas that are NOS-positive. At stage 7 and later, NOS-positive axons and glial cells are found across the entire breadth of the nerve branches (Fig. 5C , and Gibson and Nighorn, 2000) , suggesting that glia have migrated inward from the nerve surface and/or proximally along the branch from more distal regions.
To determine whether NO signaling might play a role in migration of glial cells in the antennae, antennae of L-NAME-and CPTIO-treated animals were sectioned and stained with propidium iodide and a universal NOS (uNOS) antibody. Antennal nerves from L-NAME-treated animals (either method) at approximately stage 12 were uniformly NOS-positive (as seen in untreated animals after stage 7), but associated glial cells were found only at the outer surface of the nerve (Fig. 5D ), suggesting that they stopped migrating around stage 3. To test the importance of using a bolus of the drug at late stage 2 to affect glial migration in the antenna, one animal was treated by L-NAME infusion without a bolus and dissected at stage 10. The animal exhibited antennal nerves (Fig. 5E ) that were NOS-positive across the entire nerve (as seen for untreated animals at stage 7 and later, Fig. 5C ), but a distribution of glial cells very similar to that of an untreated stage-5 animal (Fig. 5B) , suggesting that, in the absence of a bolus of L-NAME at late stage 2, glial cells could continue to migrate for at least another day. CPTIO-treated animals (Fig. 5F , examined at stage 8) exhibited the same effect on antennal-nerve organization as seen with L-NAME. These results suggest that NO plays a role in stimulating glial cell migration along the antennal nerves, as well as in the antennal lobes.
Candidate Biochemical Mechanisms for NO Effects
NO is known or believed to control or affect a number of biochemical pathways, including activation of soluble guanylyl cyclase (sGC) to produce cGMP and modification of
FIG. 3.
Continuous infusion of L-NAME or CPTIO blocks glial migration. Propidium iodide nuclear staining (A, C) and anti-5-HT labeling (B, D) of an L-NAME-treated animal (Method 2, A, B) and a CPTIO-treated animal (C, D). The former was dissected 10 days after the start of infusion (which, in L-NAME-treated animals, generally corresponds to roughly stage 5-7, but this animal lacked any of the normal markers), and the latter was dissected at apparent stage 8, 13 days after the start of infusion. Neuropil-associated glia proliferated but did not migrate, whereas the sorting-zone glia appear to have migrated normally (NA and SZ brackets in A). proteins by nitrosylation of sulfhydryl groups, blockade of acylation, and ADP-ribosylation (Hess et al., 1993; Schuman et al., 1994; Stamler, 1994; Broillet and Firestein, 1996; Hindley et al., 1997; Gibbs and Truman, 1998 ). In the current study, we asked whether the effect of NO on antennal-lobe development is mediated via the sGC-cGMP or mono-ADP-ribosylation pathways.
Previous work has indicated that NO-sGC signaling is unlikely to play a role in the glial response to ingrowing ORC axons. These cells do not produce cGMP following treatment with SNP and IBMX at stages 5 or 7, nor do they exhibit immunoreactivity for sGC at stages 3, 5, or 7 (Gibson and Nighorn, 2000) . Many antennal-lobe neurons do produce cGMP in response to SNP treatment and many are sGC-immunoreactive, so the possibility remained that the 5-HT ϩ neuron responds via this pathway. Oland et al. (1995) have shown that dendrites of the 5-HT ϩ neuron remain confined to the (nonglomerular) coarse neuropil until stage 6 -7, at which time they extend into the glomeruli and adopt their characteristic tufted arborization. If outgrowth of these dendrites is controlled by NO-sGC signaling, the 5-HT ϩ neuron should exhibit cGMP production in response to SNP treatment at stages 6 -7. Brains of untreated pupae at stage 7 were incubated in insect saline solution with the phosphodiesterase inhibitor IBMX and the nitric oxide donor SNP, as previously described (Gibson and Nighorn, 2000) , and then fixed, Vibratome-sectioned, and immunostained for cGMP and 5-HT. Although many   FIG. 4 . Protoglomeruli form in L-NAME-and CPTIO-treated animals. L-NAME (Method 2)-and CPTIO-treated animals dissected at apparent stage early 5 (A, D, G, 12 days after start of infusion), early 6 (B, E, H, 10 days after start of infusion), and 7 (C, F, I, 9 days after start of infusion). Antennal nerves were labeled with DiD (yellow) to visualize protoglomeruli (arrows, A-C); cell nuclei were stained with propidium iodide (red, D-F). The images in (A-F) are merged in (G-I). Glial cells in (E) and (F) seem to demonstrate a graded response, with migration greatest in the MGC area, where the first axons arrived, and least ventromedially (lower left of each panel). Scale bar, 50 m.
FIG. 5.
L-NAME and CPTIO block glial migration in the antennae. (A) Propidium iodide nuclear staining (red) of glial cells associated with the ORC axons in a fillet of an untreated, male stage-5 antenna. ANB, antennal nerve branch; NR, nerve rootlet (made up of primarily ORC axons); SE, sensory epithelium; dashed line, approximate plane of section in subsequent panels. There were many other PI-labeled cells in the SE; the stack was chosen to avoid including these cells in order to show only those cells under discussion. (B-F) Propidium iodide nuclear staining (red) and anti-NOS (green) labeling in antennal nerve cross-sections of untreated (B, C), L-NAME-treated (D, E), and CPTIO-treated (F) animals. During development the stage-5 antennal nerve (B) displays surface-associated glial cells and NOS-immunoreactivity (NOS-ir). The region of greater NOS-ir at upper right contains axons of nerve rootlets that have merged with the nerve, together with glial cells that have migrated down the rootlets (see Rö ssler et al., 1999; Gibson and Nighorn, 2000 ; for details). The untreated stage-7 nerve (C) displays glial cells and NOS-ir across the entire nerve, indicating glial migration (inward and/or longitudinally from more distal branches) and a change in NOS-ir which may be related. The nerve of an L-NAME-treated (Method 1) animal at approximate stage 12 (D) exhibited NOS-ir characteristic of poststage 7 nerves but a glial distribution resembling that of stage 3 animals (see text). The nerve of an animal, treated with L-NAME by Method 2 but without the bolus at the start of infusion, at approximate stage 10 (E) exhibited NOS-ir characteristic of poststage 7 nerves but a glial distribution resembling that of stage-5 animals. The nerve of a CPTIO-treated animal at stage 8 (F) was similar to that in (D). Projections correspond to thicknesses of 22 (A), 22 (B), 20 (C), 33 (D), 27 (E), and 16 m (F). Scale bar, 100 m in (A), 25 m in (B-F).
FIG. 6. The 5-HT
ϩ neuron does not exhibit detectable NO-stimulated cGMP production. Anti-cGMP (red) and anti-5-HT (blue) labeling of an untreated animal at stage 7 of development, when 5-HT ϩ neurites arborize in the glomeruli. Both antennal lobes and the subesophageal ganglion are shown in (A); a portion of the antennal lobe from a different animal is shown at higher magnification in (B). Brains were incubated in the NO donor SNP and the phosphodiesterase inhibitor IBMX to maximize NO-induced cGMP production prior to fixation. The 5-HT ϩ neurons (and the neuropil-associated glial cells) displayed no visible cGMP following NO stimulation. This has also been shown for the glial cells at earlier stages (Gibson and Nighorn, 2000) . Bracket in (B) indicates arborization of the 5-HT ϩ neuron in the MGC region. Projections represent 90 m tissue thickness. Scale bars, 100 m. cells exhibited cGMP immunoreactivity after NO stimulation, there was no evidence of staining in the 5-HT ϩ neurons (Fig. 6) . To test whether, despite the absence of visible staining, the cells in question produced cGMP at physiologically relevant levels in response to NO or were affected indirectly by other cells responding to NO via sGC, animals received injections of the sGC inhibitor ODQ at various dosages. Even at doses five to six times higher than those shown to affect synaptogenesis in Manduca (Schachtner et al., 1999b) and found to block NO-mediated cGMP production in other systems (e.g., Jacklet, 1999, 2001) , we found no effect on antennal-lobe morphology as visualized by means of DiD labeling of receptor axons and propidium iodide labeling of antennal-lobe glia (Figs. 7A  and 7B ). Lectin labeling of antennal-lobe neuron dendrites appeared normal as well (not shown), and neurites of the 5-HT ϩ neuron had normal arborizations in the lobe (Fig.  7C) .
To test for a role for NO-induced mono-ADP-ribosylation of proteins, animals were treated with the antibiotic Novobiocin, which blocks mono-ADP-ribosylation (Banasik and Ueda, 1994) . Although it is readily water soluble, Novobiocin appeared to have a graded effect centered at the site of injection, perhaps owing to rapid partitioning out of the aqueous phase into the tissue. Initial experiments produced highly variable results, which appeared to depend on the location of the syringe needle tip at injection. For the most consistent effects, subsequent injections were made into or near the optic lobe in order to introduce the drug close enough to the antennal lobe to have an effect but without damaging it. Because some variability persisted, effects were analyzed in the contralateral lobe where they were most consistent.
DiD labeling of the antennal nerve contralateral to the injection site in a stage-6 animal demonstrated that the Novobiocin treatment had no obvious effect on formation of glomeruli (Fig. 7D) . As was the case for L-NAME and CPTIO injections, glial cells in lobes containing glomeruli had not migrated; their cell bodies formed a thick layer around the neuropil, rather than surrounding the developing glomeruli (Fig. 7E) . In contrast, the sorting-zone glia appeared to have migrated normally from the antennal lobe into the proximal part of the antennal nerve (not shown). Staining of the same tissue with the lectin LEL, which labels glial processes in the antennal lobe, revealed that even though the glial-cell bodies had not migrated, many glial processes had extended to surround glomeruli (Fig. 7E) . The glial cell processes alone apparently were sufficient to stabilize and maintain glomerular architecture throughout the remainder of development, because other animals which were allowed to develop to adulthood were found to contain glomeruli which were surrounded by glial processes alone (not shown). In animals in which glial cell bodies did migrate to partially surround protoglomeruli, the 5-HT ϩ neuron dendrites were found to overgrow their normal boundaries, extending throughout the entire glomerulus (Fig. 7F) , in a manner similar to the result obtained with L-NAME treatment.
DISCUSSION
Previous research has established that key cellular interactions must occur for the antennal lobe of M. sexta to develop normal cellular architecture (reviewed by Oland and Tolbert, 1996) . The axons of olfactory receptor cells (ORCs) arriving from the antennae form a template of protoglomeruli and induce glial cells in the antennal lobe to migrate to surround these protoglomeruli (Oland and Tolbert, 1987) . The glial cells, in turn, act to stabilize the protoglomeruli and possibly confine subsequent axonal and dendritic branching to the glomerulus (Krull et al., 1994; Baumann et al., 1996) . Animals in which the antennae are removed to prevent ORC innervation of the antennal lobes never develop glomeruli (Hildebrand et al., 1979) . Glial cells remain in a rim around the perimeter of the neuropil (Oland and Tolbert, 1987) , and the dendrites of multiglomerular antennal-lobe neurons branch in a diffuse pattern, rather than in glomerular tufts (Oland et al., 1990) . The dendrites of uniglomerular projection neurons, which grow into protoglomeruli soon after their formation, are less affected (Malun et al., 1994) . In animals treated to reduce severely the number of glial cells, ORC axons still grow to the developing antennal lobe, and their terminals coalesce to form protoglomeruli, but, in the absence of a sufficient number of glia to surround these protoglomeruli, the structure is lost and both axon terminals and multiglomerular neurons again form diffuse arborizations throughout the lobe Baumann et al., 1996) . In short, the ORC axons establish the glomerular architecture via an interaction with antennal-lobe glial cells and possibly, also, via interactions with antennal-lobe neurons. Although intercellular interactions are essential, until the current study, no candidate signaling molecules had been identified.
The highly diffusible substance NO was shown to play a role in development of the antennal lobe of M. sexta by Schachtner et al. (1999a,b) . These investigators found that injection of ODQ, to inhibit the NO-stimulated soluble guanylyl cyclase present in local interneurons, at a time equivalent to our stage 5, caused a decrease in synaptotagmin expression in the developing glomeruli, indicating an effect on synapse development. Studies in other insect nervous systems indicate that NO is involved also in the maturation of neuromuscular junctions in the locust (Truman et al., 1996; Ball and Truman, 1998) , and, most interestingly, in determining the pattern of projection of photoreceptor axons in the visual system of Drosophila (Gibbs and Truman, 1998) . In the vertebrate olfactory system, studies suggest that NO synchronizes differentiation of ORC precursor cells and modulates synaptic stabilization at ORC axon terminals, as well as playing a role in regeneration of ORC axons in the adult (Roskams et al., 1994; Arnhold et al., 1997) . Therefore, NO was a reasonable candidate for us to explore as a molecular signal from ORC axons to target cells in M. sexta.
In a previous paper, we reported that throughout development and adulthood, ORC axons in M. sexta express MsNOS, and we speculated about the possible targets of NO produced by the axons (Gibson and Nighorn, 2000) . Like Schachtner et al. (1999a) , we found NO-sensitive soluble guanylyl cyclase (sGC) to be expressed in some antennal-lobe neurons, raising the possibility that a NOsGC interaction is involved in signaling between ORC axons and antennal-lobe neurons. An important question to be answered was whether ORC axons actually produced NO early in development, as ORCs show little response to odorants until pupal stage 17 (Schweitzer et al., 1976 ) and therefore might not experience the intracellular calcium increases necessary for NO production by MsNOS (Nighorn et al., 1998) .
The profound effects resulting from blockade of NO signaling in the current study, coupled with the previous results of Schachtner et al. (1999a,b) , suggest that NO is indeed produced by the ORCs during development. Our findings indicate that it is an important component of the signaling by which the ORCs influence the antennal-lobe glial cells to migrate to surround protoglomeruli, and that it also appears to restrict the outgrowth of dendrites of the 5-HT ϩ neuron to the basal (i.e., ORC-axon-free) half of each glomerulus. These specific effects of NO do not appear to be mediated by sGC, but may be mediated in part by ADPribosylation.
NO Signaling Stimulates Glial Migration
When ingrowing ORC axons were prevented from signaling via NO by either of two pharmacological manipulations, the neuropil-associated glial cells of the antennal lobe failed to migrate (Figs. 2-4) . The effects of blocking NO signaling closely resemble those of removing ORC axons, suggesting that NO signaling may be a critical mode of communication between ORC axons and glia early in development. The results of L-NAME or CPTIO treatment on migration of peripheral glial cells down the antennal nerve (Figs. 5D-5F ) provide additional support for this view.
The decreased size of the antennal nerves in many treated animals is highly unlikely to be responsible for the similarity in appearance of treated animals to deafferented animals, because previous studies (Tolbert and Sirianni, 1990) revealed that as few as 12% of the normal complement of ORC axons are sufficient to produce protoglomeruli and induce the formation of mature glomeruli. Furthermore, the axons in treated animals did often form a protoglomerular template (Fig. 4) .
The simplest explanation for these effects on glia is that NO, produced in ORC axons, diffuses to nearby glia and stimulates them to migrate. Another formal possibility is that NO acts indirectly, causing the early-invading dendrites of uniglomerular projection neurons or the ORC axons themselves to alter expression of some factor necessary for glial cell migration. Involvement of uniglomerular projection neurons appears unlikely, because glomeruli form, with a glial envelope, even when the projection neurons are surgically removed prior to glomerulus development (Oland and Tolbert, 1998) . Dendrites of local interneurons arrive at the glomeruli too late to be likely candidates (Oland et al., 1990; Oland and Tolbert, 1998) . Thus, the effect of NO on glial cell migration is probably either direct or via an effect on the ORC axons themselves, enabling them to provide the migration signal to glia.
We found that injections or infusions of NO-signaling blockers had to be started no later than late stage 2 to produce a strong effect on glial migration. Because antennal-lobe glia do not begin to migrate until stage 5, our results may indicate that NO initiates, at stage 2-3, a developmental program that is necessary to allow glia to migrate several days later. NO has been shown to inhibit the transcription factors AP-1 and NF-B p50 by S-nitrosylation (Tabuchi et al., 1994; DelaTorre et al., 1997; Colasanti and Persichini, 2000) , and to promote cell migration as well as cell-surface expression of integrin ␣ v ␤ 3 , known to mediate cell migration in gliomas (Murohara et al., 1999; Uhm et al., 1999; Lee et al., 2000; Platten et al., 2000) .
It is interesting to note that, while the neuropilassociated glia of the antennal lobe and the glia of the antennae failed to migrate following blockade of NO signaling, the sorting-zone glia, which migrate distally from the developing antennal lobe , appear to have migrated normally in all cases (Figs. 2-4) . The current results could indicate that the sorting zone glia are induced to migrate by a signal other than NO. They have been shown to differ from neuropil-associated glia of the antennal lobe in other ways; for example, sorting-zone glia require the presence of ORC axons for proliferation while antennal-lobe glia do not Oland and Tolbert, 1989) . Previous research indicates that sortingzone glia have responded, via proliferation and migration, to ORC axon arrival by stage 3 . It is therefore possible that initiation of the sorting-zone glial response to ORC axons would have occurred prior to the establishment of effective levels of anti-NO-signaling drugs in our test animals. This will be difficult to test, as earlier injections of L-NAME cause developmental arrest.
NO Arrests Outgrowth of 5-HT
؉ Dendrites L-NAME-treated animals in which glomeruli did form provide a useful insight into the role of NO in determining outgrowth of the dendrites of the 5-HT ϩ neuron (Fig. 2) . It was noted previously that the 5-HT ϩ dendrites normally ramify in areas of the glomerulus not occupied by the ORC axons (Sun et al., 1993) , but when NO signaling was blocked, the dendrites were able to arborize throughout the region occupied by the ORC axons. The ability of NO to cause growth-cone collapse and thus halt process extension has been documented and attributed to blockade of growthcone protein acylation (Hess et al., 1993; Rentería and Constantine-Paton, 1996) . An attractive hypothesis is that, in M. sexta, such a process serves to prevent the majority of 5-HT ϩ dendrites from entering ORN territory within the glomerulus. An alternative possibility is that an effect of NO on glial cells alters some growth-limiting effect on 5-HT ϩ dendrites by the glia, although this seems less likely The same section stained with propidium iodide (red) and LEL, which stains glial-cell membranes (green). Most glia failed to migrate, yet extended processes to surround glomeruli. Asterisks mark the same glomerulus in the two images to aid in alignment. (F) Propidium iodide nuclear stain (red) and anti-5-HT labeling (blue) of several glomeruli from a different, posteclosion animal demonstrating the dendrite overgrowth which was seen in those animals that displayed enough glial migration to define glomerular areas. The arborization of the 5-HT ϩ neuron resembles that seen in L-NAME-treated animals ( because glial cells outline the glomeruli and are not present at the equator, where 5-HT ϩ dendritic branches normally terminate.
Mechanisms of NO Action
Several lines of evidence reported here indicate that the NO-cGMP signaling pathway is not involved in either the glial cell migration or 5-HT ϩ dendrite-outgrowth responses to NO. Previous studies indicate that NO does not induce detectable cGMP production in antennal-lobe glia at the relevant stages (3-7; Gibson and Nighorn, 2000) . Doublelabeling for 5-HT and cGMP in NO-stimulated control brains at stage 7, when the 5-HT ϩ neuron dendrites extend into the glomeruli, indicates that the 5-HT ϩ neuron does not exhibit cGMP production either (Fig. 6) . Furthermore, the sGC inhibitor ODQ produced antennal lobes in which the glomeruli appeared normal, with typical arborization of the 5-HT ϩ neuron dendrites and the normal arrangement of neuropil-associated glia (Figs. 7A-7C ).
Although sGC is the best characterized target of NO, several other downstream effectors of NO signaling are known. Direct NO-mediated nitrosylation of proteins, a feature common to these other mechanisms, can in turn lead to direct gating of cyclic nucleotide-gated channels (Broillet and Firestein, 1996; Broillet, 2000) , to modification of properties of extracellular matrix proteins (Sato et al., 2001) , and to covalent attachment of ADP-ribose or NAD (McDonald and Moss, 1993; Schuman et al., 1994; Zwiers, 1995, 1997) . ADP-ribosylation has been shown to affect the targeting or attachment of proteins to the membrane (Philibert and Zwiers, 1995) , the adhesion properties of fibronectin (Terashima et al., 1998) , and polymerization of actin and tubulin mediated, at least in part, by Ras superfamily GTPases (Jalink et al., 1994; Allport et al., 1996 ; see also Philibert and Zwiers, 1997 ; for a review). When we blocked ADP-ribosylation using Novobiocin, we found that the neuropil-associated glia did not migrate, yet they extended processes to surround glomeruli (Fig. 7E) . The animals were given only a single Novobiocin dose early in development (late 2 or early 3), well before the time at which glia normally extend processes and migrate. Therefore, these results most likely indicate an uncoupling of glial cell process extension and cell-body migration by Novobiocin. Because L-NAME and CPTIO treatment appear to have blocked both process extension and cell-body migration in these glia, it is possible that NO promotes process extension by one mechanism (not yet identified in this system), while mediating migration via an effect on ADP-ribosylation. Novobiocin was found also to mimic the effect of L-NAME and CPTIO on arborization of the dendrites of the 5-HT ϩ neuron (Fig. 7F) , suggesting that ORC axons restrict the outgrowth of 5-HT ϩ dendrites via an NO-mediated increase in ADP-ribosylation of one or more growth cone proteins.
In summary, the work presented here suggests that NO serves as an important messenger in communication between the ORC axons and the antennal-lobe glia and the 5-HT ϩ neuron of the antennal lobe. The fact that blockade of glial migration at stage 5 requires blockade of NO signaling no later than late stage 2 may indicate that NO works in part by initiating critical developmental programs. Moreover, the ability of Novobiocin to mimic some effects of NO-signaling blockade may indicate a role for NOinduced ADP-ribosylation.
